Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY.
Hematology Global Marketing, Beckman Coulter Diagnostics, Miami, FL.
Prenat Diagn. 2019 Feb;39(3):157-164. doi: 10.1002/pd.5422. Epub 2019 Feb 10.
Microarray testing is the recommended first-tier diagnostic test for women who undergo invasive prenatal diagnostic procedures. It is well-established that microarray analysis provides information regarding copy number for changes (or copy number variants, CNVs) that may be below the resolution level of standard chromosome analysis, and that such CNVs are not related to maternal age. What may not be appreciated by ordering providers, however, are the technical differences among laboratories with respect to the established laboratory cutoff values for reporting, the definition of targeted versus nontargeted regions, and how these differences may affect the interpretation and reporting of findings which, in turn, affects counseling and possible follow-up testing of family members. Here, we provide a detailed explanation of these technical factors and clarify how they practically impact diagnostic results.
微阵列测试是推荐用于接受侵入性产前诊断程序的女性的首选一线诊断测试。已经确立的是,微阵列分析提供了关于可能低于标准染色体分析分辨率水平的拷贝数变化(或拷贝数变异,CNVs)的信息,并且这种 CNVs 与母体年龄无关。然而,下订单的提供者可能没有意识到的是,实验室之间在报告的既定实验室截止值、目标区域与非目标区域的定义以及这些差异如何影响发现的解释和报告方面存在技术差异,而这反过来又会影响对家庭成员的咨询和可能的后续测试。在这里,我们详细解释了这些技术因素,并阐明了它们如何实际影响诊断结果。